From 1 February 2021, eletriptan, rizatriptan, sumatriptan and zolmitriptan can be supplied to patients as a Schedule 3 medicine for the acute relief of migraine.
This scheduling change will make it easier for people with migraine to access medication to manage their symptoms.
However, triptans are not appropriate for all people living with migraine, and the choice to use them should consider patient and symptom factors.
Guild Learning and Development has developed an online module called Supplying triptans as a pharmacist only medicine for migraine.
The module provides an update on the complexities of migraine, management considerations, and guides pharmacists to confidently manage the supply of triptans for the management of migraine.
To enrol in this course please visit
